Pharma: Other News To Note
Mundipharma International Ltd., of Cambridge, UK, said the European Commission approved combination therapy flutiform (fluticasone propionate/formoterol fumarate) for the maintenance treatment of asthma.
To continue reading subscribe now to BioWorld Today
Learn More about BioWorld Today
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.